Atlas Trials

Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B

Clinical trial NCT03349008 · UNKNOWN

Trial details

NCT number
NCT03349008
Sponsor
Cttq
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis bLiver Inflammation
Start date
2017-11-25
Primary completion
2019-12-31
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.